# Royal Philips

Royal Philips is a Corporate Investor based in Amsterdam, Netherlands.

## Overview

- **Organization type:** Corporate Investor
- **Headquarters:** Amsterdam, Netherlands
- **Region:** Europe
- **Address:** Amstelplein 2, 1096 BC Amsterdam, Netherlands
- **Founded:** 1891
- **Assets under management:** Undisclosed
- **Website:** www.philips.nl
- **LinkedIn:** https://www.linkedin.com/company/philips

## Regulatory record

- **Reports private funds:** No

## About

Corporate Investor

## Sectors

- Digital Health
- MedTech
- Consumer Health

## Offices

- Eindhoven, Netherlands

## People

- Roy Jakobs — CEO, Chairman of the Board of Management and Executive Committee
- Charlotte Hanneman — CFO, Member of the Board of Management
- Marnix van Ginneken — Chief ESG & Legal Officer, Chair of Philips Foundation Board

## Questions

### Who runs investment decisions at Royal Philips?

The Executive Committee, chaired by CEO Roy Jakobs, sets the strategic direction, with R&D allocation and M&A executed at the operational level. Charlotte Hanneman has served as CFO since 2024, overseeing the balance-sheet capacity for acquisitions and internal venture funding. The Board of Management retains final authority on large transactions.

### Does Royal Philips commit to external funds or only direct investments?

Philips does not operate as a traditional fund-of-funds investor. Its capital deployment is concentrated on internal R&D programs and direct acquisitions of companies in diagnostics, connected care, and health informatics. It runs a blockchain research lab and the Philips Foundation Impact Investments vehicle, but the parent company's primary investing motion is corporate M&A rather than LP commitments.

### What sectors does Philips prioritize for capital deployment?

Philips concentrates its R&D and acquisition spend on diagnostic imaging, image-guided therapy, patient monitoring, ultrasound, and personal health. Within those domains, it emphasizes software, AI, and data interoperability. The firm does not invest in pure-play pharma, biotech, or health insurance, maintaining a tight focus on medical devices and health informatics.

## Related profiles

- [Royal Pavilion Holdings](https://altss.com/profile/royal-pavilion-holdings)
- [Royal Sea Capital](https://altss.com/profile/royal-sea-capital)

---

Last updated: 2026-05-29T11:58:41.677Z

Canonical page: https://altss.com/profile/royal-philips

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology